Silverarc Capital Management’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Silverarc Capital Management’s Portfolio SRRA Stock Details SRRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-443,381	Closed	-$14.2M	–	90
2022 Q1	$14.2M	Buy	443,381 +251,336	+131%	+$7.21M	5.88%	4
2021 Q4	$4.17M	Buy	192,045 +28,559	+17%	+$629K	1.69%	18
2021 Q3	$3.58M	Buy	163,486 +24,181	+17%	+$484K	2.03%	17
2021 Q2	$2.71M	Buy	139,305 +4,624	+3%	+$84K	1.21%	29
2021 Q1	$2.32M	Sell	134,681 -319	-0.2%	-$5.05K	1.27%	31
2020 Q4	$2.16M	Buy	+135,000	New	+$1.87M	1.26%	32

Other funds holding SRRA

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Versor Investments New York $47.5M AUM 100.43% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Silverarc Capital Management's SRRA Position: Q2 2022 in Review

Silverarc Capital Management sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q2 2022, closing a stake of 443,381 shares — an estimated $14.2M sold.

Silverarc Capital Management first reported a position in SRRA in Q4 2020 and held it in 6 quarters. The position peaked at $14.2M in Q1 2022. 109 funds tracked by Wall St. Rank hold SRRA as of Q2 2022.

Silverarc Capital Management reported no remaining Sierra Oncology, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Silverarc Capital Management sold 443,381 Sierra Oncology, Inc. Common Stock shares in Q2 2022, an estimated $14.2M.
Silverarc Capital Management first reported a position in Sierra Oncology, Inc. Common Stock in Q4 2020 and held it in 6 quarters.
Silverarc Capital Management's Sierra Oncology, Inc. Common Stock position peaked at $14.2M in Q1 2022.
109 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q2 2022.

Based on Silverarc Capital Management's 13F filing for Q2 2022, filed 25 Jul 2022.